Chemotherapy in advanced pancreatic adenocarcinoma

被引：22

作者：

Kollmannsberger, C

Peters, HD

Fink, U

机构：

[1] Tech Univ Munich, Chirurg Klin & Poliklin, Abt Chirurg Onkol, Klinikum Rechts Isar,Sect Surg Oncol, D-81675 Munich, Germany

[2] Univ Tubingen, Dept Haematol Oncol, Med Ctr, D-72076 Tubingen, Germany

[3] Leibniz Univ Hannover, Sch Med, Dept Immunopharmacol, D-30625 Hannover, Germany

来源：

CANCER TREATMENT REVIEWS | 1998年 / 24卷 / 02期

关键词：

D O I：

10.1016/S0305-7372(98)90079-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：133 / 156

页数：24

共 137 条

[91]

NIEDERHUBER JE, 1995, CANCER, V76, P1671, DOI 10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO

[92]

2-R

[93]

OBYRNE K, 1994, BR J CANC S21, V67, P21

[94] CHEMOTHERAPY PROLONGS SURVIVAL IN INOPERABLE PANCREATIC-CARCINOMA [J].

PALMER, KR ;

KERR, M ;

KNOWLES, G ;

CULL, A ;

CARTER, DC ;

LEONARD, RCF .

BRITISH JOURNAL OF SURGERY, 1994, 81 (06) :882-885

[95]

PATEL SR, 1991, INVEST NEW DRUG, V9, P53

[96]

PAZDUR R, 1992, CANCER, V70, P2073, DOI 10.1002/1097-0142(19921015)70:8<2073::AID-CNCR2820700810>3.0.CO

[97]

2-A

[98] Phase II trial of ZD1694 (Tomudex(TM)) in patients with advanced pancreatic cancer [J].

Pazdur, R ;

Meropol, NJ ;

Casper, ES ;

Fuchs, C ;

Douglass, HO ;

Vincent, M ;

Abbruzzese, JL .

INVESTIGATIONAL NEW DRUGS, 1995, 13 (04) :355-358

[99]

RAYMONT E, 1997, EUR J CANCER, V33, P686

[100] PHASE-II TRIAL OF PALA AND 6-METHYLMERCAPTOPURINE RIBOSIDE (MMPR) IN COMBINATION WITH 5-FLUOROURACIL IN ADVANCED PANCREATIC-CANCER [J].

REDEI, I ;

GREEN, F ;

HOFFMAN, JP ;

WEINER, LM ;

SCHER, R ;

ODWYER, PJ .

INVESTIGATIONAL NEW DRUGS, 1994, 12 (04) :319-321

← 5 6 7 8 9 10 11 12 13 14 →